Tissue distribution and developmental expression of the messenger RNA encoding angiogenin.

New blood vessel growth occurs during normal fetal development and in diseases such as cancer and diabetes. The polypeptide angiogenin induces new blood vessel growth in two biological assays and may play a role in the vascular development of the fetus and in the neovascularization that accompanies diseases and wound healing. A complementary DNA probe for human angiogenin was used to examine the tissue distribution of angiogenin messenger RNA (mRNA) in the developing rat and in selected transformed cell lines. Angiogenin mRNA was detected predominantly in adult liver but was also detectable at low levels in other tissues. The expression of the angiogenin gene in rat liver was found to be developmentally regulated; mRNA levels were low in the developing fetus, increased in the neonate, and maximal in the adult. The amount of angiogenin mRNA in human HT-29 colon carcinoma and SK-HEP hepatoma cells was not greater than that in normal rat liver. These results demonstrate that angiogenin is predominantly expressed in adult liver, that the pattern of angiogenin gene expression is not temporally related to vascular development in the rat, and that the transformed cells studied do not contain more angiogenin mRNA than does normal liver. If angiogenin activity is controlled at the transcriptional level, the results of this study suggest that the primary function of angiogenin in vivo may be in processes other than the regulation of vascular growth.

[1]  J. L. Bethune,et al.  Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. , 1985, Biochemistry.

[2]  G. Giménez-Gallego,et al.  Pure brain-derived acidic fibroblast growth factor is a potent angiogenic vascular endothelial cell mitogen with sequence homology to interleukin 1. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[3]  R. Shapiro,et al.  Human placental ribonuclease inhibitor abolishes both angiogenic and ribonucleolytic activities of angiogenin. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[4]  A. Feinberg,et al.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. , 1983, Analytical biochemistry.

[5]  J. Fiddes,et al.  Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor. , 1986, Science.

[6]  R. Shapiro,et al.  Characteristic ribonucleolytic activity of human angiogenin. , 1986, Biochemistry.

[7]  J. Denekamp,et al.  Endothelial proliferation in tumours and normal tissues: continuous labelling studies. , 1984, British Journal of Cancer.

[8]  K. Kurachi,et al.  Sequence of the cDNA and gene for angiogenin, a human angiogenesis factor. , 1985, Biochemistry.

[9]  R. Derynck,et al.  Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor. , 1986, Science.

[10]  L. Liotta.  Angiogenesis: Isolation of a protein that stimulates blood vessel growth , 1985, Nature.

[11]  David C. Lee,et al.  Cloning and sequence analysis of a cDNA for rat transforming growth factor-α , 1985, Nature.

[12]  J F Riordan,et al.  Amino acid sequence of human tumor derived angiogenin. , 1985, Biochemistry.

[13]  S. O’Brien,et al.  Human endothelial cell growth factor: cloning, nucleotide sequence, and chromosome localization. , 1986, Science.

[14]  T. Maciag,et al.  High and low molecular weight forms of endothelial cell growth factor. , 1982, The Journal of biological chemistry.

[15]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[16]  R. Cotran,et al.  MONONUCLEAR PHAGOCYTES (KUPFFER CELLS) AND ENDOTHELIAL CELLS , 1972, The Journal of cell biology.